L W Frick - JoVE Visualize

Showing results (1-10 of 10) with videos related to

Pageof 1

Sort By:

Current Opinion in Drug Discovery & Development|August 4, 2009

High-throughput pharmacokinetics: cassette dosingM K Bayliss, L W Frick

Biochemistry|August 3, 1993

Identification of the nucleotide binding site of HIV-1 reverse transcriptase using dTTP as a photoaffinity labelN Cheng, B M Merrill, G R Painter, et al.

Antimicrobial Agents and Chemotherapy|December 1, 1994

Pharmacokinetics, oral bioavailability, and metabolism in mice and cynomolgus monkeys of (2'R,5'S-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl] cytosine, an agent active against human immunodeficiency virus and human hepatitis B virusL W Frick, C U Lambe, L St John, et al.

Biochemical and Biophysical Research Communications|July 15, 1988

Effects of 3'-azido-3'-deoxythymidine on the deoxynucleotide triphosphate pools of cultured human cellsL W Frick, D J Nelson, M H St Clair, et al.

Journal of Medicinal Chemistry|June 6, 1997

Substituted N-phenylisothioureas: potent inhibitors of human nitric oxide synthase with neuronal isoform selectivityB G Shearer, S Lee, J A Oplinger, et al.

Xenobiotica; the Fate of Foreign Compounds in Biological Systems|February 1, 1996

Hplc-nmr identification of the human urinary metabolites of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl] cytosine, a nucleoside analogue active against human immunodeficiency virus (HIV)J P Shockcor, R M Wurm, L W Frick, et al.

Antimicrobial Agents and Chemotherapy|November 1, 1993

Pharmacokinetics, oral bioavailability, and metabolic disposition in rats of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl] cytosine, a nucleoside analog active against human immunodeficiency virus and hepatitis B virusL W Frick, L St John, L C Taylor, et al.

Journal of Medicinal Chemistry|February 5, 1993

Novel 6-alkoxypurine 2',3'-dideoxynucleosides as inhibitors of the cytopathic effect of the human immunodeficiency virusC L Burns, M H St Clair, L W Frick, et al.

Antimicrobial Agents and Chemotherapy|December 1, 1992

The anti-hepatitis B virus activities, cytotoxicities, and anabolic profiles of the (-) and (+) enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosineP A Furman, M Davis, D C Liotta, et al.

Nucleosides, Nucleotides & Nucleic Acids|April 25, 2000

Synthesis and evaluation of a series of 2'-deoxy analogues of the antiviral agent 5,6-dichloro-2-isopropylamino-1-(beta-L-ribofuranosyl)-1H-benzimidazole (1263W94)J H Chan, S D Chamberlain, K K Biron, et al.

Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:

Pageof 1

Current Opinion in Drug Discovery & Development|August 4, 2009

High-throughput pharmacokinetics: cassette dosingM K Bayliss, L W Frick

Biochemistry|August 3, 1993

Identification of the nucleotide binding site of HIV-1 reverse transcriptase using dTTP as a photoaffinity labelN Cheng, B M Merrill, G R Painter, et al.

Antimicrobial Agents and Chemotherapy|December 1, 1994

Pharmacokinetics, oral bioavailability, and metabolism in mice and cynomolgus monkeys of (2'R,5'S-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl] cytosine, an agent active against human immunodeficiency virus and human hepatitis B virusL W Frick, C U Lambe, L St John, et al.

Biochemical and Biophysical Research Communications|July 15, 1988

Effects of 3'-azido-3'-deoxythymidine on the deoxynucleotide triphosphate pools of cultured human cellsL W Frick, D J Nelson, M H St Clair, et al.

Journal of Medicinal Chemistry|June 6, 1997

Substituted N-phenylisothioureas: potent inhibitors of human nitric oxide synthase with neuronal isoform selectivityB G Shearer, S Lee, J A Oplinger, et al.

Xenobiotica; the Fate of Foreign Compounds in Biological Systems|February 1, 1996

Hplc-nmr identification of the human urinary metabolites of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl] cytosine, a nucleoside analogue active against human immunodeficiency virus (HIV)J P Shockcor, R M Wurm, L W Frick, et al.

Antimicrobial Agents and Chemotherapy|November 1, 1993

Pharmacokinetics, oral bioavailability, and metabolic disposition in rats of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl] cytosine, a nucleoside analog active against human immunodeficiency virus and hepatitis B virusL W Frick, L St John, L C Taylor, et al.

Journal of Medicinal Chemistry|February 5, 1993

Novel 6-alkoxypurine 2',3'-dideoxynucleosides as inhibitors of the cytopathic effect of the human immunodeficiency virusC L Burns, M H St Clair, L W Frick, et al.

Antimicrobial Agents and Chemotherapy|December 1, 1992

The anti-hepatitis B virus activities, cytotoxicities, and anabolic profiles of the (-) and (+) enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosineP A Furman, M Davis, D C Liotta, et al.

Nucleosides, Nucleotides & Nucleic Acids|April 25, 2000

Synthesis and evaluation of a series of 2'-deoxy analogues of the antiviral agent 5,6-dichloro-2-isopropylamino-1-(beta-L-ribofuranosyl)-1H-benzimidazole (1263W94)J H Chan, S D Chamberlain, K K Biron, et al.

Pageof 1